Neoplasms, Colorectal Completed Phase 1 Trials for Capecitabine (DB01101)

Also known as: Colorectal Neoplasms / Colorectal Neoplasm / Neoplasms,Colorectal

IndicationStatusPhase
DBCOND0036298 (Neoplasms, Colorectal)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00536809Phase I/II Study of Lapatinib in Combination With Oxaliplatin and Capecitabine in Subjects With Advanced Colorectal CancerTreatment
NCT00291486Capecitabine and 131I-huA33 in Patients With Metastatic Colorectal CancerTreatment
NCT00532909Phase I Vandetanib Plus Capecitabine, Oxaliplatin and Bevacizumab for Metastatic Colorectal CancerTreatment